Cerner (NASDAQ:CERN) had its price target increased by research analysts at Morgan Stanley from $58.00 to $62.00 in a research note issued on Friday, BenzingaRatingsTable reports. The firm presently has an “underweight” rating on the stock. Morgan Stanley’s price objective points to a potential downside of 10.73% from the stock’s previous close.

Several other equities research analysts have also commented on the company. Jefferies Financial Group upgraded Cerner from a “hold” rating to a “buy” rating and upped their price objective for the stock from $75.00 to $90.00 in a research report on Wednesday, April 22nd. Barclays lowered their price target on shares of Cerner from $72.00 to $67.00 and set an “equal weight” rating on the stock in a report on Wednesday, April 29th. SunTrust Banks lowered shares of Cerner from a “buy” rating to a “hold” rating and raised their price target for the company from $66.00 to $72.00 in a research report on Friday, May 1st. SVB Leerink assumed coverage on shares of Cerner in a research report on Monday, April 13th. They issued an “outperform” rating and a $78.00 price objective for the company. Finally, Stephens started coverage on Cerner in a research report on Monday, July 6th. They set an “equal weight” rating and a $75.00 target price on the stock. Two research analysts have rated the stock with a sell rating, six have given a hold rating and thirteen have given a buy rating to the stock. Cerner presently has a consensus rating of “Buy” and an average price target of $78.08.

NASDAQ:CERN opened at $69.45 on Friday. The firm’s fifty day moving average is $70.10 and its two-hundred day moving average is $70.00. The firm has a market cap of $21.14 billion, a price-to-earnings ratio of 41.84, a PEG ratio of 2.18 and a beta of 0.87. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.90 and a current ratio of 2.04. Cerner has a one year low of $53.08 and a one year high of $80.90.

Cerner (NASDAQ:CERN) last issued its quarterly earnings data on Wednesday, July 29th. The company reported $0.63 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.61 by $0.02. The business had revenue of $1.33 billion during the quarter, compared to analysts’ expectations of $1.36 billion. Cerner had a return on equity of 18.19% and a net margin of 9.23%. The company’s revenue for the quarter was down 7.0% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.66 EPS. As a group, equities research analysts predict that Cerner will post 2.5 earnings per share for the current fiscal year.

In other news, insider Tracy L. Platt sold 6,948 shares of the stock in a transaction dated Friday, July 31st. The shares were sold at an average price of $71.38, for a total value of $495,948.24. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO David Brent Shafer sold 14,282 shares of the business’s stock in a transaction dated Monday, May 11th. The stock was sold at an average price of $68.52, for a total transaction of $978,602.64. The disclosure for this sale can be found here. Over the last three months, insiders sold 128,875 shares of company stock valued at $9,146,690. 0.33% of the stock is owned by corporate insiders.

Several institutional investors have recently modified their holdings of CERN. Flagship Harbor Advisors LLC increased its holdings in shares of Cerner by 151.5% in the second quarter. Flagship Harbor Advisors LLC now owns 425 shares of the company’s stock valued at $29,000 after purchasing an additional 256 shares during the last quarter. Ellevest Inc. grew its holdings in Cerner by 53.0% in the 2nd quarter. Ellevest Inc. now owns 514 shares of the company’s stock valued at $35,000 after buying an additional 178 shares in the last quarter. NewSquare Capital LLC acquired a new stake in shares of Cerner in the 1st quarter worth $38,000. Simon Quick Advisors LLC raised its holdings in shares of Cerner by 1,440.5% during the 1st quarter. Simon Quick Advisors LLC now owns 647 shares of the company’s stock worth $41,000 after acquiring an additional 605 shares during the period. Finally, Campbell Wealth Management purchased a new position in shares of Cerner during the 2nd quarter worth $42,000. Institutional investors and hedge funds own 82.72% of the company’s stock.

Cerner Company Profile

Cerner Corporation provides health care information technology solutions and tech-enabled services in the United States and internationally. The company offers Cerner Millennium architecture, a person-centric computing framework, which includes clinical, financial, and management information systems that allow providers to access an individual's electronic health record (EHR) at the point of care, and organizes and delivers information for physicians, nurses, laboratory technicians, pharmacists, front- and back-office professionals, and consumers.

Read More: Cryptocurrencies

Analyst Recommendations for Cerner (NASDAQ:CERN)

Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with MarketBeat.com's FREE daily email newsletter.